A patient with disseminated intravascular coagulation (DIC) secondary to obstetric complications is receiving supportive care including fresh frozen plasma and platelet transfusions. During your assessment, you note a decrease in urine output and increasing edema. Which of the following is the most appropriate nursing intervention to address these changes?

B) Notify the healthcare provider about potential renal impairment for further evaluation.

A) Increase the rate of intravenous fluids to improve renal perfusion.

B) Notify the healthcare provider about potential renal impairment for further evaluation.

C) Administer additional diuretics as prescribed to manage fluid overload.

D) Monitor the patient's renal function tests and continue current care plan.

A patient has been diagnosed with disseminated intravascular coagulation (DIC) secondary to obstetric complications. Based on the new diagnostic results, which of the following nursing actions is the priority to prevent further deterioration of the patient's condition?

C) Prepare for the administration of fresh frozen plasma and platelet transfusions.

A) Administer supplemental oxygen to address potential respiratory compromise.

B) Monitor liver function tests closely to detect worsening hepatic function.

C) Prepare for the administration of fresh frozen plasma and platelet transfusions.

D) Educate the patient about the signs and symptoms of hemorrhagic events.

A patient with worsening thrombocytopenia, declining oxygen saturation, altered mental status, and elevated liver enzymes is experiencing a deterioration in her clinical condition. What is the most appropriate nursing action to prioritize at this time?

B) Prepare for potential intubation and mechanical ventilation.

A) Administer cryoprecipitate to address low fibrinogen levels.

B) Prepare for potential intubation and mechanical ventilation.

C) Start anticoagulation therapy to manage thrombotic activity.

D) Increase the flow rate of supplemental oxygen via nasal cannula.

A patient with worsening thrombocytopenia, declining oxygen saturation, and altered mental status is suspected to be developing multiple organ dysfunction syndrome (MODS). As a nurse, what is the priority intervention to address the patient's current condition?

C) Initiate mechanical ventilation to improve oxygenation.

A) Administer cryoprecipitate to increase fibrinogen levels.

B) Start anticoagulation therapy to manage thrombotic activity.

C) Initiate mechanical ventilation to improve oxygenation.

D) Increase the rate of IV fluids to support blood pressure.

A patient with disseminated intravascular coagulation (DIC) and signs of acute respiratory distress syndrome (ARDS) has been started on low-dose anticoagulation therapy. What is the nurse's priority action to monitor for complications associated with this treatment?

D) Evaluate the patient's skin for any signs of bleeding or bruising.

A) Monitor the patient's urine output for signs of renal impairment.

B) Assess the patient's neurological status for any changes.

C) Check the patient's blood pressure and heart rate every 4 hours.

D) Evaluate the patient's skin for any signs of bleeding or bruising.

A patient with disseminated intravascular coagulation (DIC) is showing signs of acute respiratory distress syndrome (ARDS) and reduced ejection fraction. Which intervention should the nurse prioritize to address the risk of further complications?

B) Monitor respiratory status closely and prepare for potential intubation if respiratory distress worsens.

A) Administer high-dose anticoagulation therapy immediately to prevent thrombus formation.

B) Monitor respiratory status closely and prepare for potential intubation if respiratory distress worsens.

C) Increase fluid administration to improve cardiac output and manage hypotension.

D) Focus on pain management to reduce systemic stress and improve cardiac function.

A patient is experiencing increasing hemodynamic instability with a blood pressure of 85/50 mmHg, heart rate of 130 beats per minute, oxygen saturation of 88% on high-flow oxygen, thrombocytopenia, elevated lactate, and worsening renal function. Which intervention should the nurse anticipate implementing first to address the hemodynamic instability?

A) Initiate vasopressor therapy to support blood pressure

B) Administer supplemental oxygen to improve saturation

C) Prepare for renal replacement therapy to address kidney function

D) Transfuse platelets to correct thrombocytopenia

A patient with ARDS is experiencing worsening hemodynamic instability despite low-dose anticoagulation therapy and cryoprecipitate transfusions. Her blood pressure is 85/50 mmHg, heart rate is 130 bpm, and oxygen saturation is 88% on high-flow oxygen. Lab tests show a platelet count of 40,000/µL, lactate level of 4.5 mmol/L, and creatinine level of 2.3 mg/dL. What is the most appropriate immediate nursing intervention to support this patient's condition?

B) Prepare for the administration of vasopressor therapy.

A) Increase the oxygen flow rate to improve oxygenation.

B) Prepare for the administration of vasopressor therapy.

C) Administer additional cryoprecipitate transfusions.

D) Initiate renal replacement therapy immediately.

A pregnant patient with disseminated intravascular coagulation (DIC) is receiving cryoprecipitate transfusions and anticoagulation therapy. What is the nurse's priority action when monitoring this patient?

B) Assess the patient's neurological status for signs of cerebral involvement

A) Monitor the patient's input and output to assess renal function

B) Assess the patient's neurological status for signs of cerebral involvement

C) Evaluate skin integrity to detect further petechiae or ecchymoses

D) Measure the patient's blood pressure every 30 minutes to identify hypotension

A patient with disseminated intravascular coagulation (DIC) is receiving continuous renal replacement therapy (CRRT) and anticoagulation treatment. The patient develops petechiae, ecchymoses, and a hemoglobin level of 7.8 g/dL. Which nursing intervention is the most appropriate to address the patient's current condition?

C) Notify the healthcare provider and prepare to administer cryoprecipitate to replenish fibrinogen levels.

A) Administer a transfusion of packed red blood cells to address anemia.

B) Increase the rate of anticoagulation therapy to prevent further thrombus formation.

C) Notify the healthcare provider and prepare to administer cryoprecipitate to replenish fibrinogen levels.

D) Discontinue CRRT to reduce the risk of further bleeding complications.

disseminated intravascular coagulation in pregnancy - Nursing Case Study

Pathophysiology

• Primary mechanism: In pregnancy, placental damage or retained fetal tissue can trigger excessive release of tissue factor into the bloodstream, activating the coagulation cascade and leading to widespread clotting.

• Secondary mechanism: The formation of microthrombi throughout the vasculature consumes clotting factors and platelets, resulting in a paradoxical increase in bleeding risk due to depleted clotting components.

• Key complication: This imbalance between clot formation and clot breakdown can lead to severe hemorrhage, organ dysfunction, and can be life-threatening if not promptly managed.

Patient Profile

Demographics:

32-year-old female, school teacher

History:

• Key past medical history: Gestational hypertension in previous pregnancy

• Current medications: Prenatal vitamins, low-dose aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased bleeding and bruising

• Key symptoms: Hematuria, petechiae, shortness of breath, fatigue

• Vital signs: Temperature 100.4°F, heart rate 112 bpm, blood pressure 98/60 mmHg, respiratory rate 22 breaths/min, oxygen saturation 94% on room air

Section 1

New Diagnostic Results:

Following the initial presentation, the medical team ordered a series of laboratory tests to evaluate the coagulation profile and organ function, given the suspicion of disseminated intravascular coagulation (DIC). The laboratory results revealed a significantly prolonged prothrombin time (PT) of 18 seconds and an activated partial thromboplastin time (aPTT) of 45 seconds, both indicating a coagulopathy. The fibrinogen level was critically low at 150 mg/dL, and the D-dimer was elevated to 5,000 ng/mL, suggestive of ongoing fibrinolysis and thrombotic activity. Platelet counts were also reduced to 75,000 cells/µL, confirming thrombocytopenia. Furthermore, a comprehensive metabolic panel showed a mild elevation in liver enzymes, with AST at 58 U/L and ALT at 62 U/L, suggesting potential liver involvement.

In conjunction with these findings, a urinalysis indicated gross hematuria, consistent with her initial complaints. The complete blood count revealed a hemoglobin level of 9.5 g/dL, indicating anemia likely due to ongoing blood loss. These results confirmed the diagnosis of DIC, triggered by obstetric complications, and highlighted the need for immediate intervention to manage coagulopathy and prevent further organ dysfunction. Given the patient's decreasing oxygen saturation and tachycardia, there was growing concern about potential respiratory compromise, possibly due to pulmonary microthrombi or progressing anemia, necessitating close monitoring and potentially supplemental oxygen therapy.

The clinical team recognized the urgency of addressing the underlying cause, stabilizing the patient's hemodynamic status, and preventing further complications. This involved initiating supportive care with fresh frozen plasma and platelet transfusions to replenish clotting factors and platelets. Close observation for signs of worsening organ function, particularly in the liver and kidneys, became paramount, as these organs are susceptible to ischemic injury in the context of DIC. The new diagnostic results provided a clearer picture of the patient's condition, guiding the multidisciplinary team's approach to stabilize her and mitigate the risk of severe hemorrhagic events. This set the stage for ongoing monitoring and further interventions tailored to the evolving clinical scenario.

Section 2

New Complications:

Despite the initial interventions with fresh frozen plasma and platelet transfusions, the patient's condition began to deteriorate further. Over the next few hours, her vital signs indicated increasing instability: blood pressure dropped to 90/60 mmHg, heart rate escalated to 120 beats per minute, and her oxygen saturation continued to decline, now at 88% on room air. This prompted the need for supplemental oxygen via nasal cannula, which only modestly improved her saturation levels. The patient also started to exhibit signs of altered mental status, becoming increasingly lethargic and disoriented, which raised concerns about cerebral hypoperfusion or microvascular thrombi affecting the brain.

Repeat laboratory tests revealed worsening thrombocytopenia, with platelet counts dropping to 50,000 cells/µL, and a further decrease in fibrinogen levels to 120 mg/dL. Liver enzymes continued to rise, with AST and ALT now reaching 85 U/L and 90 U/L, respectively, indicating progressive hepatic involvement. Additionally, there was evidence of acute kidney injury, as reflected by an elevated creatinine level of 2.1 mg/dL, suggesting renal impairment likely exacerbated by microthrombi or hypoperfusion. The patient's coagulation profile remained deranged, underscoring the persistence of the consumptive coagulopathy.

These developments necessitated a reassessment of the current management plan. The clinical team deliberated on the need for more aggressive interventions, such as cryoprecipitate to address the critically low fibrinogen levels and possible anticoagulation therapy to manage ongoing thrombotic activity, while weighing the risks of exacerbating bleeding. Furthermore, the team considered the potential requirement for mechanical ventilation should respiratory function continue to decline. With the patient's condition evolving rapidly, maintaining a delicate balance between correcting coagulopathy and preventing further organ damage became crucial, setting the stage for a more intensive level of monitoring and care.

Section 3

As the clinical team continued to evaluate the patient's deteriorating status, new diagnostic results provided further insight into her condition. A chest X-ray was ordered due to her declining oxygen saturation and revealed bilateral infiltrates consistent with acute respiratory distress syndrome (ARDS), a complication that often accompanies severe cases of disseminated intravascular coagulation (DIC). This finding corroborated the clinical suspicion of worsening respiratory function and potential lung involvement due to microthrombi or inflammatory processes.

Simultaneously, an echocardiogram was performed to assess cardiac function given the patient's tachycardia and hypotension. The results indicated a reduced ejection fraction of 45%, suggesting possible cardiac strain or early signs of heart failure, likely secondary to the systemic stress and hypoperfusion. The team recognized the importance of differentiating between primary cardiac issues and those arising from the systemic effects of DIC, which could guide the tailoring of supportive therapies.

In light of these diagnostic findings, the clinical team decided to initiate low-dose anticoagulation therapy cautiously to address the microvascular thrombi while continuously monitoring for bleeding risks. Cryoprecipitate transfusions were administered to elevate fibrinogen levels, aiming to stabilize the coagulation cascade. These interventions highlighted the importance of dynamic clinical reasoning, as the team balanced the complexities of managing both thrombotic and hemorrhagic risks, ultimately hoping to improve the patient's multi-organ function and prevent further complications.

Section 4

As the clinical team continued to monitor the patient, they observed a change in her status that warranted immediate attention. Despite the initiation of low-dose anticoagulation therapy and cryoprecipitate transfusions, the patient exhibited signs of increasing hemodynamic instability. Her blood pressure dropped further to 85/50 mmHg, and her heart rate climbed to 130 beats per minute. These findings suggested a worsening of her cardiac output and raised concerns about potential progression to shock. Concomitantly, her oxygen saturation remained precariously low at 88% on high-flow oxygen, indicating persistent respiratory compromise likely due to the ongoing ARDS.

In response to these developments, the clinical team ordered repeat laboratory tests, including a complete blood count, coagulation profile, and metabolic panel, to assess the impact of their interventions and identify any new complications. The results showed a further decrease in platelet count to 40,000/µL, a rising lactate level at 4.5 mmol/L, and worsening renal function with a creatinine level of 2.3 mg/dL. These lab values underscored the complexity of the patient's condition, highlighting the continued risk of bleeding due to thrombocytopenia, exacerbation of tissue hypoperfusion indicated by elevated lactate, and possible acute kidney injury.

Faced with these challenges, the team engaged in critical clinical reasoning to adjust their management strategy. They deliberated on the need to escalate supportive measures, potentially considering vasopressor support to maintain hemodynamic stability and optimize organ perfusion. Additionally, the need for renal replacement therapy was evaluated in light of the patient's deteriorating renal function. The clinical team recognized the delicate balance required between aggressive intervention and the potential for exacerbating the patient's already compromised hemostatic and organ systems. This pivotal moment in the patient's journey emphasized the importance of continuous reassessment and adaptation of the treatment plan in response to the evolving clinical picture.

Section 5

As the clinical team implemented vasopressor support to stabilize the patient's blood pressure and optimize cardiac output, they also initiated continuous renal replacement therapy (CRRT) to address the worsening renal function. Despite these measures, the patient exhibited a new complication: she developed petechiae and ecchymoses on her arms and legs, indicating an exacerbation of her coagulopathy. Her hemoglobin decreased to 7.8 g/dL, suggesting significant blood loss, and her D-dimer levels surged, further confirming the hypercoagulable state associated with disseminated intravascular coagulation (DIC).

In response to these alarming changes, the team prioritized the careful titration of anticoagulation therapy to balance the risk of thrombosis against the potential for severe bleeding. They also increased the frequency of cryoprecipitate transfusions to replenish fibrinogen levels, aiming to stabilize her coagulation profile. Concurrently, the patient required closer monitoring of her neurological status due to the risk of cerebral involvement from microvascular thrombi or hemorrhage, necessitating a multidisciplinary approach involving hematology, nephrology, and critical care specialists.

These developments underscored the complexity of managing DIC in pregnancy, as the team navigated the fine line between necessary interventions and their potential complications. The patient's journey highlighted the importance of dynamic clinical reasoning, where each decision was informed by evolving clinical data, the patient's overall condition, and the anticipated trajectory of her illness. This phase called for continuous vigilance and adaptability in the treatment strategy, setting the stage for the next critical juncture in her care.